Lobbying client · LD-2 disclosures
Av Therapeutics Inc.
New York
25 filings from 2 registrants · 2017–2023 · latest filed Jul 19, 2023
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
6 filings
Budget/Appropriations
BUD
4 filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- Robert Van Heuvelen Van Heuvelen Strategies, LLCCovered position: Chief of Staff to Senator Kent Conrad7 filingsthrough 2020
- Valerie West Van Heuvelen Strategies, LLCCovered position: Deputy Director of Cong. Affairs, Bureau of Reclamation7 filingsthrough 2020
- Stephen Douglas Ward Van Heuvelen Strategies, LLCCovered position: Chief of Staff to Senator Jeff Bingaman7 filingsthrough 2020
- Bobby Cunningham The Vogel Group1 filing
The filings
The 20 most recent of 25 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: av-therapeutics-inc.